id	sid	eid	entity	type
ajlm-933	1	1	samson m. haumba university research co.	PERSON
ajlm-933	1	2	llc	GPE
ajlm-933	1	3	mitsuru toda	PERSON
ajlm-933	1	4	cdc	ORG
ajlm-933	1	5	atlanta	GPE
ajlm-933	1	6	georgia	GPE
ajlm-933	1	7	united states	GPE
ajlm-933	1	8	cdc	ORG
ajlm-933	1	9	atlanta	GPE
ajlm-933	1	10	georgia	GPE
ajlm-933	1	11	united states	ORG
ajlm-933	1	12	rossana jeffries university research co.	ORG
ajlm-933	1	13	llc	GPE
ajlm-933	1	14	peter ehrenkranz global development	ORG
ajlm-933	1	15	melinda gates foundation	ORG
ajlm-933	1	16	seattle	GPE
ajlm-933	1	17	washington	GPE
ajlm-933	1	18	united states munyaradzi pasipamire ministry of health eswatini national aids	ORG
ajlm-933	1	19	cdc	ORG
ajlm-933	1	20	nomthandazo lukhele ministry of health eswatini national aids	ORG
ajlm-933	1	21	mazibuko ministry of health eswatini national aids	ORG
ajlm-933	1	22	mandzisi mkhontfo university research co.	ORG
ajlm-933	1	23	llc	GPE
ajlm-933	1	24	rachel m. smith	PERSON
ajlm-933	1	25	cdc	ORG
ajlm-933	1	26	atlanta	GPE
ajlm-933	1	27	georgia	GPE
ajlm-933	1	28	united states	GPE
ajlm-933	1	29	tom chiller mycotic diseases branch	PERSON
ajlm-933	1	30	cdc	ORG
ajlm-933	1	31	atlanta	GPE
ajlm-933	1	32	georgia	GPE
ajlm-933	1	33	united states	GPE
ajlm-933	2	1	2014–2015	CARDINAL
ajlm-933	3	1	afr j	PERSON
ajlm-933	3	2	a933 https://doi.org/10.4102/ajlm.v9i1.933	GPE
ajlm-933	3	3	2014–2015	CARDINAL
ajlm-933	3	4	samson m. haumba	PERSON
ajlm-933	3	5	mitsuru toda	PERSON
ajlm-933	3	6	rossana jeffries	PERSON
ajlm-933	3	7	peter ehrenkranz	PERSON
ajlm-933	3	8	trong ao	PERSON
ajlm-933	3	9	nomthandazo lukhele	PERSON
ajlm-933	3	10	mandzisi mkhontfo	PERSON
ajlm-933	3	11	rachel m. smith	PERSON
ajlm-933	3	12	tom chiller	PERSON
ajlm-933	3	13	05 nov. 2018	DATE
ajlm-933	3	14	07 apr.	CARDINAL
ajlm-933	4	1	2020	DATE
ajlm-933	4	2	29 july 2020	DATE
ajlm-933	5	1	2020	DATE
ajlm-933	11	1	between august 2014	DATE
ajlm-933	11	2	march 2015	DATE
ajlm-933	12	1	4	CARDINAL
ajlm-933	12	2	200	CARDINAL
ajlm-933	12	3	lfa	ORG
ajlm-933	13	1	two	CARDINAL
ajlm-933	14	1	100	CARDINAL
ajlm-933	14	2	200	CARDINAL
ajlm-933	14	3	crag lfa	PERSON
ajlm-933	14	4	crag lfa	PERSON
ajlm-933	15	1	4%	PERCENT
ajlm-933	15	2	8/182	CARDINAL
ajlm-933	15	3	95%	PERCENT
ajlm-933	16	1	2–8	DATE
ajlm-933	16	2	200	CARDINAL
ajlm-933	16	3	8%	PERCENT
ajlm-933	16	4	95%	PERCENT
ajlm-933	16	5	3–15	CARDINAL
ajlm-933	16	6	100	CARDINAL
ajlm-933	17	1	crag lfa	PERSON
ajlm-933	17	2	100%	PERCENT
ajlm-933	17	3	95%	PERCENT
ajlm-933	17	4	59–100	CARDINAL
ajlm-933	17	5	80%	PERCENT
ajlm-933	17	6	95%	PERCENT
ajlm-933	17	7	cd4	ORG
ajlm-933	17	8	200	CARDINAL
ajlm-933	18	1	forty-three	CARDINAL
ajlm-933	18	2	99	CARDINAL
ajlm-933	18	3	100	CARDINAL
ajlm-933	19	1	6%	PERCENT
ajlm-933	19	2	100	CARDINAL
ajlm-933	22	1	neoformans	NORP
ajlm-933	22	2	cryptococcus gattii	ORG
ajlm-933	24	1	4	CARDINAL
ajlm-933	24	2	200	CARDINAL
ajlm-933	24	3	the world health organization	ORG
ajlm-933	24	4	2014	DATE
ajlm-933	24	5	6%	PERCENT
ajlm-933	24	6	278 000	QUANTITY
ajlm-933	24	7	100	CARDINAL
ajlm-933	24	8	approximately 223 100	CARDINAL
ajlm-933	24	9	the same year,	DATE
ajlm-933	24	10	2014	DATE
ajlm-933	24	11	181 100	CARDINAL
ajlm-933	24	12	75%	PERCENT
ajlm-933	24	13	135	CARDINAL
ajlm-933	24	14	lfa	ORG
ajlm-933	25	1	a median of three weeks	DATE
ajlm-933	25	2	cd4	ORG
ajlm-933	25	3	200	CARDINAL
ajlm-933	28	1	crag lfa	PERSON
ajlm-933	28	2	crag lfa	PERSON
ajlm-933	29	1	cgh hsr	PERSON
ajlm-933	29	2	2014-139	DATE
ajlm-933	32	1	500	CARDINAL
ajlm-933	33	1	320 651	CARDINAL
ajlm-933	33	2	1 093 2381	QUANTITY
ajlm-933	33	3	18 years old	DATE
ajlm-933	33	4	abbott laboratories	ORG
ajlm-933	33	5	chicago	GPE
ajlm-933	33	6	illinois	GPE
ajlm-933	33	7	united states	GPE
ajlm-933	34	1	cd4 ≤ 350	ORG
ajlm-933	34	2	beckton dickinson	PERSON
ajlm-933	34	3	san jose	GPE
ajlm-933	34	4	california	GPE
ajlm-933	34	5	united states	GPE
ajlm-933	35	1	cd4	ORG
ajlm-933	35	2	200	CARDINAL
ajlm-933	36	1	18 august 2014 to	DATE
ajlm-933	36	2	19	CARDINAL
ajlm-933	37	1	5 days	DATE
ajlm-933	38	1	first	ORDINAL
ajlm-933	39	1	immy	PRODUCT
ajlm-933	39	2	norman	PERSON
ajlm-933	39	3	oklahoma	GPE
ajlm-933	39	4	united states	GPE
ajlm-933	46	1	crag lfa	PERSON
ajlm-933	47	1	0.7 mg/kg	QUANTITY
ajlm-933	47	2	2 weeks	DATE
ajlm-933	47	3	400 mg	QUANTITY
ajlm-933	47	4	8 weeks	DATE
ajlm-933	47	5	200 mg	QUANTITY
ajlm-933	48	1	the first 2 weeks	DATE
ajlm-933	48	2	8 weeks	DATE
ajlm-933	48	3	400 mg	QUANTITY
ajlm-933	48	4	south african	NORP
ajlm-933	48	5	2013	DATE
ajlm-933	48	6	2 weeks	DATE
ajlm-933	50	1	crag lfa	PERSON
ajlm-933	52	1	5 min	TIME
ajlm-933	52	2	300	CARDINAL
ajlm-933	52	3	the same day	DATE
ajlm-933	53	1	2 °	QUANTITY
ajlm-933	53	2	8 °	QUANTITY
ajlm-933	53	3	72	CARDINAL
ajlm-933	53	4	h. cd4	PERSON
ajlm-933	53	5	next day	DATE
ajlm-933	53	6	crag lfa	PERSON
ajlm-933	53	7	cd4	ORG
ajlm-933	53	8	200	CARDINAL
ajlm-933	54	1	daily	DATE
ajlm-933	56	1	crag lfa	PERSON
ajlm-933	58	1	odense, denmark	ORG
ajlm-933	59	1	wilson	ORG
ajlm-933	59	2	95%	PERCENT
ajlm-933	59	3	15	CARDINAL
ajlm-933	59	4	statacorp	ORG
ajlm-933	59	5	texas	GPE
ajlm-933	59	6	united states	GPE
ajlm-933	60	1	313	CARDINAL
ajlm-933	60	2	58%	PERCENT
ajlm-933	60	3	182/313	CARDINAL
ajlm-933	60	4	cd4	ORG
ajlm-933	60	5	200	CARDINAL
ajlm-933	60	6	1	CARDINAL
ajlm-933	61	1	182	CARDINAL
ajlm-933	61	2	79%	PERCENT
ajlm-933	61	3	21%	PERCENT
ajlm-933	61	4	38/182	CARDINAL
ajlm-933	61	5	1	CARDINAL
ajlm-933	62	1	1	CARDINAL
ajlm-933	62	2	august 2014 to march 2015	DATE
ajlm-933	63	1	1	CARDINAL
ajlm-933	63	2	200	CARDINAL
ajlm-933	63	3	august 2014 to march 2015	DATE
ajlm-933	64	1	182	CARDINAL
ajlm-933	64	2	cd4	ORG
ajlm-933	64	3	200	CARDINAL
ajlm-933	64	4	42%	PERCENT
ajlm-933	64	5	76/182	CARDINAL
ajlm-933	64	6	35 years	DATE
ajlm-933	64	7	30–42	CARDINAL
ajlm-933	64	8	61%	PERCENT
ajlm-933	64	9	111/182	DATE
ajlm-933	64	10	1	CARDINAL
ajlm-933	65	1	86%	PERCENT
ajlm-933	65	2	156/182	DATE
ajlm-933	65	3	10%	PERCENT
ajlm-933	65	4	3%	PERCENT
ajlm-933	65	5	5/189	CARDINAL
ajlm-933	65	6	shiselweni	ORG
ajlm-933	65	7	2%	PERCENT
ajlm-933	65	8	3/182	CARDINAL
ajlm-933	66	1	almost half	CARDINAL
ajlm-933	66	2	47%	PERCENT
ajlm-933	66	3	41%	PERCENT
ajlm-933	66	4	75/182	CARDINAL
ajlm-933	66	5	12%	PERCENT
ajlm-933	66	6	21/182	CARDINAL
ajlm-933	67	1	62%	PERCENT
ajlm-933	67	2	34%	PERCENT
ajlm-933	67	3	61/182	CARDINAL
ajlm-933	67	4	4%	PERCENT
ajlm-933	67	5	8/182	CARDINAL
ajlm-933	68	1	more than half	CARDINAL
ajlm-933	68	2	54%	PERCENT
ajlm-933	68	3	99/182	DATE
ajlm-933	68	4	40%	PERCENT
ajlm-933	68	5	5%	PERCENT
ajlm-933	68	6	182	CARDINAL
ajlm-933	68	7	cd4	ORG
ajlm-933	68	8	200	CARDINAL
ajlm-933	68	9	56%	PERCENT
ajlm-933	68	10	102/182	DATE
ajlm-933	68	11	100	CARDINAL
ajlm-933	68	12	forty-three percent	PERCENT
ajlm-933	68	13	44/102	CARDINAL
ajlm-933	68	14	57%	PERCENT
ajlm-933	68	15	cd4	ORG
ajlm-933	68	16	100	CARDINAL
ajlm-933	68	17	199	CARDINAL
ajlm-933	68	18	69%	PERCENT
ajlm-933	68	19	55/80	CARDINAL
ajlm-933	68	20	31%	PERCENT
ajlm-933	68	21	25/80	CARDINAL
ajlm-933	69	1	8%	PERCENT
ajlm-933	69	2	95%	PERCENT
ajlm-933	69	3	3–15	CARDINAL
ajlm-933	69	4	cd4	ORG
ajlm-933	69	5	100	CARDINAL
ajlm-933	70	1	200	CARDINAL
ajlm-933	70	2	4%	PERCENT
ajlm-933	70	3	8/182	CARDINAL
ajlm-933	70	4	95%	PERCENT
ajlm-933	70	5	2–8	DATE
ajlm-933	70	6	1	CARDINAL
ajlm-933	71	1	eight	CARDINAL
ajlm-933	71	2	100	CARDINAL
ajlm-933	71	3	100	CARDINAL
ajlm-933	72	1	199	CARDINAL
ajlm-933	72	2	4%	PERCENT
ajlm-933	72	3	8/182	CARDINAL
ajlm-933	72	4	95%	PERCENT
ajlm-933	72	5	2–8	DATE
ajlm-933	73	1	47%	PERCENT
ajlm-933	73	2	cd4	ORG
ajlm-933	73	3	100	CARDINAL
ajlm-933	73	4	199	CARDINAL
ajlm-933	73	5	53%	PERCENT
ajlm-933	73	6	100	CARDINAL
ajlm-933	74	1	76	DATE
ajlm-933	74	2	5%	PERCENT
ajlm-933	74	3	4/76	CARDINAL
ajlm-933	75	1	three	CARDINAL
ajlm-933	75	2	four	CARDINAL
ajlm-933	75	3	one	CARDINAL
ajlm-933	76	1	32%	PERCENT
ajlm-933	76	2	12/38	CARDINAL
ajlm-933	76	3	cd4	ORG
ajlm-933	76	4	100	CARDINAL
ajlm-933	76	5	199	CARDINAL
ajlm-933	76	6	68%	PERCENT
ajlm-933	76	7	26/38	CARDINAL
ajlm-933	76	8	cd4	ORG
ajlm-933	76	9	100	CARDINAL
ajlm-933	77	1	fifteen percent	PERCENT
ajlm-933	77	2	4/26	CARDINAL
ajlm-933	77	3	cd4	ORG
ajlm-933	77	4	100	CARDINAL
ajlm-933	78	1	four	CARDINAL
ajlm-933	78	2	one	CARDINAL
ajlm-933	78	3	csf crag	PERSON
ajlm-933	78	4	three	CARDINAL
ajlm-933	78	5	1	CARDINAL
ajlm-933	79	1	168	CARDINAL
ajlm-933	79	2	82%	PERCENT
ajlm-933	79	3	137/168	CARDINAL
ajlm-933	79	4	18%	PERCENT
ajlm-933	79	5	31/168	CARDINAL
ajlm-933	80	1	forty-six percent	PERCENT
ajlm-933	80	2	77/168	CARDINAL
ajlm-933	80	3	100	CARDINAL
ajlm-933	80	4	199	CARDINAL
ajlm-933	80	5	54%	PERCENT
ajlm-933	80	6	91/168	CARDINAL
ajlm-933	80	7	cd4	ORG
ajlm-933	80	8	100	CARDINAL
ajlm-933	81	1	25%	PERCENT
ajlm-933	81	2	23/91	CARDINAL
ajlm-933	81	3	cd4	ORG
ajlm-933	81	4	100	CARDINAL
ajlm-933	81	5	22%	PERCENT
ajlm-933	81	6	17/77	CARDINAL
ajlm-933	81	7	cd4	ORG
ajlm-933	81	8	100	CARDINAL
ajlm-933	81	9	199	CARDINAL
ajlm-933	81	10	crag lfa	PERSON
ajlm-933	81	11	100%	PERCENT
ajlm-933	81	12	95%	PERCENT
ajlm-933	81	13	59–100	CARDINAL
ajlm-933	81	14	80%	PERCENT
ajlm-933	81	15	95%	PERCENT
ajlm-933	81	16	cd4	ORG
ajlm-933	81	17	200	CARDINAL
ajlm-933	82	1	seven	CARDINAL
ajlm-933	82	2	33	CARDINAL
ajlm-933	82	3	crag lfa	PERSON
ajlm-933	82	4	128	CARDINAL
ajlm-933	82	5	zero	CARDINAL
ajlm-933	82	6	crag lfa	PERSON
ajlm-933	82	7	2	CARDINAL
ajlm-933	83	1	2	CARDINAL
ajlm-933	83	2	200	CARDINAL
ajlm-933	83	3	august 2014 to march 2015	DATE
ajlm-933	84	1	100	CARDINAL
ajlm-933	84	2	crag lfa	PERSON
ajlm-933	84	3	crag lfa	PERSON
ajlm-933	84	4	100%	PERCENT
ajlm-933	84	5	95%	PERCENT
ajlm-933	84	6	59–100	CARDINAL
ajlm-933	84	7	81%	PERCENT
ajlm-933	84	8	95%	PERCENT
ajlm-933	84	9	71–89	CARDINAL
ajlm-933	85	1	seven	CARDINAL
ajlm-933	85	2	16	CARDINAL
ajlm-933	85	3	crag lfa	PERSON
ajlm-933	85	4	68	CARDINAL
ajlm-933	85	5	zero	CARDINAL
ajlm-933	85	6	crag lfa	PERSON
ajlm-933	85	7	3	CARDINAL
ajlm-933	86	1	3	CARDINAL
ajlm-933	86	2	100	CARDINAL
ajlm-933	86	3	august 2014 to march 2015	DATE
ajlm-933	88	1	100	CARDINAL
ajlm-933	88	2	8%	PERCENT
ajlm-933	88	3	2014	DATE
ajlm-933	88	4	6%2	CARDINAL
ajlm-933	88	5	uganda5	ORG
ajlm-933	89	1	tanzania	GPE
ajlm-933	89	2	zambia	GPE
ajlm-933	89	3	28%	PERCENT
ajlm-933	89	4	african	NORP
ajlm-933	89	5	kenya	GPE
ajlm-933	89	6	malawi	GPE
ajlm-933	89	7	uganda	GPE
ajlm-933	89	8	zimbabwe	GPE
ajlm-933	89	9	27%.19	CARDINAL
ajlm-933	89	10	100	CARDINAL
ajlm-933	89	11	the era	DATE
ajlm-933	89	12	90	CARDINAL
ajlm-933	89	13	iv22	PERSON
ajlm-933	90	1	43%	PERCENT
ajlm-933	90	2	100	CARDINAL
ajlm-933	92	1	cd4	ORG
ajlm-933	92	2	200	CARDINAL
ajlm-933	92	3	100	CARDINAL
ajlm-933	92	4	100	CARDINAL
ajlm-933	93	1	5%	PERCENT
ajlm-933	93	2	15%	PERCENT
ajlm-933	94	1	tanzanian	NORP
ajlm-933	95	1	ministry of health	ORG
ajlm-933	95	2	2018	DATE
ajlm-933	95	3	cd4	ORG
ajlm-933	95	4	100	CARDINAL
ajlm-933	95	5	cd4	ORG
ajlm-933	95	6	less than 25%	PERCENT
ajlm-933	95	7	lymphocytes,12	ORG
ajlm-933	96	1	crag lfa kits	PERSON
ajlm-933	97	1	the swaziland national hiv/aids programme	ORG
ajlm-933	97	2	swaziland health laboratory services	ORG
ajlm-933	99	1	firstly	ORDINAL
ajlm-933	99	2	one	CARDINAL
ajlm-933	101	1	secondly	ORDINAL
ajlm-933	101	2	100	CARDINAL
ajlm-933	104	1	crag lfa	PERSON
ajlm-933	105	1	6%	PERCENT
ajlm-933	105	2	100	CARDINAL
ajlm-933	108	1	weekly	DATE
ajlm-933	110	1	lfa	ORG
ajlm-933	111	1	cdc	ORG
ajlm-933	111	2	cdc-atlanta	ORG
ajlm-933	112	1	lfa	PRODUCT
ajlm-933	114	1	khudzie	NORP
ajlm-933	114	2	lydia mpango	PERSON
ajlm-933	114	3	marianne calnan	PERSON
ajlm-933	114	4	kelly rose-clarke	PERSON
ajlm-933	114	5	greg greene	PERSON
ajlm-933	114	6	thokozani maseko	PERSON
ajlm-933	114	7	mulungie mwembo	PERSON
ajlm-933	114	8	dan gama	PERSON
ajlm-933	114	9	african	NORP
ajlm-933	115	1	brendan r. jackson	PERSON
ajlm-933	115	2	alexander jordan	PERSON
ajlm-933	115	3	juliana da silva	PERSON
ajlm-933	118	1	p.e.	GPE
ajlm-933	118	2	t.a.	GPE
ajlm-933	118	3	t.c.	GPE
ajlm-933	119	1	r.j.	PERSON
ajlm-933	120	1	m.p.	GPE
ajlm-933	120	2	t.a.	GPE
ajlm-933	120	3	n.l.	GPE
ajlm-933	120	4	s.m.	GPE
ajlm-933	122	1	m.t.	GPE
ajlm-933	122	2	r.j.	PERSON
ajlm-933	122	3	m.t.	GPE
ajlm-933	122	4	m.m.	PERSON
ajlm-933	122	5	r.j.	PERSON
ajlm-933	124	1	american	NORP
ajlm-933	124	2	the united states	GPE
ajlm-933	124	3	the united states	GPE
ajlm-933	124	4	university research co.	ORG
ajlm-933	124	5	llc	ORG
ajlm-933	124	6	neeraj kak	PERSON
ajlm-933	125	1	african	NORP
ajlm-933	130	1	march 2018	DATE
ajlm-933	130	2	2016	CARDINAL
ajlm-933	131	1	2018	DATE
ajlm-933	132	1	2018	DATE
ajlm-933	132	2	18	CARDINAL
ajlm-933	133	1	http://www.who.int/hiv/pub/guidelines/cryptococcal-disease/en/	NORP
ajlm-933	133	2	smith rm	PERSON
ajlm-933	135	1	lancet	ORG
ajlm-933	136	1	2017;17(8):873–881	CARDINAL
ajlm-933	138	1	2011	DATE
ajlm-933	139	1	2018 jan 10	DATE
ajlm-933	140	1	rolfes ma	PERSON
ajlm-933	140	2	rajasingham r	PERSON
ajlm-933	142	1	2014;20(1):45	CARDINAL
ajlm-933	143	1	100	CARDINAL
ajlm-933	144	1	clin infect dis	ORG
ajlm-933	145	1	2010;51(4):448	CARDINAL
ajlm-933	145	2	bauman sk	PERSON
ajlm-933	148	1	opin med	PERSON
ajlm-933	149	1	2012;6(3):245–251.	CARDINAL
ajlm-933	151	1	mnisi z	ORG
ajlm-933	152	1	swaziland	GPE
ajlm-933	152	2	first	ORDINAL
ajlm-933	153	1	9th	ORDINAL
ajlm-933	153	2	23	CARDINAL
ajlm-933	153	3	paris	GPE
ajlm-933	153	4	france	GPE
ajlm-933	154	1	5837	DATE
ajlm-933	156	1	2017	CARDINAL
ajlm-933	157	1	2018	DATE
ajlm-933	157	2	18	CARDINAL
ajlm-933	159	1	swaziland central	ORG
ajlm-933	160	1	2017	CARDINAL
ajlm-933	162	1	2017	DATE
ajlm-933	162	2	2019	DATE
ajlm-933	163	1	http://sz.one.un.org/content/unct/swaziland/en/home/news-centre/news/swaziland-releases-population-count-from-2017-housing-and-popula.html world health organization	ORG
ajlm-933	165	1	2017	CARDINAL
ajlm-933	166	1	2018 jan 12	DATE
ajlm-933	167	1	http://www.who.int/hiv/pub/guidelines/advanced-hiv-disease/en/	NORP
ajlm-933	167	2	2013	DATE
ajlm-933	170	1	https://doi.org/10.4102/sajhivmed.v14i2.82 jarvis jn	PERSON
ajlm-933	170	2	south africa	GPE
ajlm-933	171	1	clin infect dis	ORG
ajlm-933	172	1	2009;48(7):856–862	CARDINAL
ajlm-933	173	1	https://doi.org/10.1086/597262 ministry of health: swaziland	ORG
ajlm-933	174	1	swaziland	GPE
ajlm-933	175	1	2018	DATE
ajlm-933	176	1	18 may 2019	CARDINAL
ajlm-933	177	1	greene g	PERSON
ajlm-933	177	2	sriruttan	PERSON
ajlm-933	179	1	curr opin	PERSON
ajlm-933	180	1	2017;12(2):139–147	CARDINAL
ajlm-933	181	1	two	CARDINAL
ajlm-933	181	2	ethiopia	GPE
ajlm-933	182	1	plos one	PERSON
ajlm-933	184	1	https://doi.org/10.1371/journal.pone.0075585 boulware dr	ORG
ajlm-933	184	2	meya db	PERSON
ajlm-933	184	3	muzoora	PERSON
ajlm-933	186	1	2014;370(26):2487–2498	CARDINAL
ajlm-933	187	1	https://doi.org/10.1056/nejmoa1312884 jarvis jn	PERSON
ajlm-933	188	1	south africa	GPE
ajlm-933	189	1	plos one	PERSON
ajlm-933	190	1	2013;8(7):e69288	CARDINAL
ajlm-933	191	1	cambodia	GPE
ajlm-933	192	1	plos one.	PERSON
ajlm-933	194	1	https://doi.org/10.1371/journal.pone.0013856 mfinanga s	PERSON
ajlm-933	195	1	kivuyo sl	PERSON
ajlm-933	196	1	tanzania	GPE
ajlm-933	196	2	zambia	GPE
ajlm-933	197	1	lancet	ORG
ajlm-933	199	1	https://doi.org/10.1016/s0140-6736(15)60164-7 hakim j	PERSON
ajlm-933	199	2	szubert aj	PERSON
ajlm-933	199	3	africa	LOC
ajlm-933	201	1	2017;377(3):233–245	CARDINAL
ajlm-933	201	2	abassi m	PERSON
ajlm-933	204	1	oxford university	ORG
ajlm-933	204	2	2017	CARDINAL
ajlm-933	205	1	joint united nations programme	ORG
ajlm-933	206	1	90-90-90	CARDINAL
ajlm-933	207	1	2014	DATE
ajlm-933	208	1	18 may 2019	CARDINAL
ajlm-933	209	1	ford	PERSON
ajlm-933	211	1	clin infect dis	ORG
ajlm-933	212	1	s110	PERSON
ajlm-933	213	1	denning dw	PERSON
ajlm-933	213	2	annual	DATE
ajlm-933	213	3	500 000	QUANTITY
ajlm-933	213	4	2020	DATE
ajlm-933	214	1	phil trans royal soc b	PERSON
ajlm-933	214	2	biol sci	PERSON
ajlm-933	215	1	ford	ORG
ajlm-933	215	2	jarvis jn	PERSON
ajlm-933	217	1	clin infect dis	ORG
ajlm-933	218	1	2018;66(suppl_2):s152	CARDINAL
ajlm-933	218	2	magambo ka	PERSON
ajlm-933	218	3	kalluvya	PERSON
ajlm-933	218	4	kapoor sw	PERSON
ajlm-933	218	5	mwanza	GPE
ajlm-933	218	6	tanzania	GPE
ajlm-933	220	1	2014;17(1):19040	CARDINAL
ajlm-933	221	1	scriven je	PERSON
ajlm-933	221	2	lalloo	PERSON
ajlm-933	221	3	africa	LOC
ajlm-933	222	1	lancet	ORG
ajlm-933	223	1	2016;16(8):891–892	CARDINAL
ajlm-933	225	1	lancet	ORG
ajlm-933	226	1	2017;17(8):790–791	CARDINAL
ajlm-933	229	1	2011	DATE
ajlm-933	230	1	2019	DATE